Increased aggregation response of platelets in patients with inflammatory bowel disease

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of gastroenterology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00535-005-1721-xPMID 16501857
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Elevated Circulating Platelet-Derived Microparticles in Patients with Active Inflammatory Bowel Disease

  2005cited by this paper
• Platelets in Inflammatory Bowel Disease: Clinical, Pathogenic, and Therapeutic Implications

  2004cited by this paper
• Platelets: signaling cells in the immune continuum.

  2004cited by this paper
• Thromboembolism—an Important Manifestation of Inflammatory Bowel Disease

  2004cited by this paper
• Is inflammatory bowel disease an independent and disease specific risk factor for thromboembolism?

  2004cited by this paper
• Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients

  2003cited by this paper
• Microparticles in cardiovascular diseases.

  2003cited by this paper
• Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients.

  2003cited by this paper
• Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in inflammatory bowel disease?

  2002cited by this paper
• Function and Clinical Significance of Platelet-Derived Microparticles

  2001cited by this paper
• Development and Assessment of Enzyme Immunoassay for Platelet-derived Microparticles

  2001cited by this paper
• Mean platelet volume: a useful marker of inflammatory bowel disease activity

  2001cited by this paper
• Expression of platelet P-selectin and detection of soluble P-selectin, NPY and RANTES in patients with inflammatory bowel disease

  2000cited by this paper
• Platelet factor 4 and β‐thromboglobulin in inflammatory bowel disease and giant cell arteritis

  2000cited by this paper
• Epinephrine induced platelet aggregation in rat platelet-rich plasma.

  2000cited by this paper
• Acute sympathetic hyperfunction in overlapping syndromes of systemic lupus erythematosus and polymyositis.

  1998cited by this paper
• Platelets circulate in an activated state in inflammatory bowel disease.

  1994cited by this paper
• Platelet-derived microparticle formation involves glycoprotein IIb-IIIa. Inhibition by RGDS and a Glanzmann's thrombasthenia defect.

  1993cited by this paper
• Thromboembolism in inflammatory bowel disease: role of platelets.

  1993cited by this paper
• Platelet Count, Platelet Function, Coagulation Activity and Fibrinolysis in the Acute Phase of Inflammatory Bowel Disease

  1990cited by this paper
• Altered autonomic function in patients with arthritis or with chronic myofascial pain

  1989cited by this paper
• Coated mesalazine (5-aminosalicylic acid) versus sulphasalazine in the treatment of active ulcerative colitis: a randomised trial.

  1989cited by this paper
• Pathogenesis of Crohn's disease: multifocal gastrointestinal infarction.

  1989cited by this paper
• Increases in plasma neuropeptide Y concentrations during sympathetic activation in man.

  1986cited by this paper
• Clinical pharmacology of platelets.

  1977cited by this paper
• Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study.

  1976cited by this paper
• Thrombocytosis in ulcerative colitis and Crohn's disease.

  1973cited by this paper

• Preparation of gastrointestinal pH-responsive zein coated tea polyphenol-heparin hydrocolloids using for inflammatory bowel disease therapy.

  2025cites this paper
• Predicting complications in paediatric ulcerative colitis: A longitudinal multicentre cohort study

  2024cites this paper
• Abnormal platelet parameters in inflammatory bowel disease: a systematic review and meta-analysis

  2024cites this paper
• Fecal calprotectin and platelet count predict histologic disease activity in pediatric ulcerative colitis: results from a projection-predictive feature selection

  2024cites this paper
• ATHEROSCLEROTIC CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

  2024cites this paper
• One Case of Ulcerative Colitis with Secondary Thrombocytosis and Literature Review

  2023cites this paper
• Adsorptive cytapheresis for ulcerative colitis with focus on removing platelets and platelet‐aggregates

  2022cites this paper
• Thromboembolic Events in Patients with Inflammatory Bowel Disease: A Comprehensive Overview

  2022cites this paper
• Epidemiology and Risk Factors of Portal Venous System Thrombosis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis

  2022cites this paper
• Activation of Platelet NLRP3 Inflammasome in Crohn’s Disease

  2021cites this paper
• Probiotic-Derived Polyphosphate Accelerates Intestinal Epithelia Wound Healing through Inducing Platelet-Derived Mediators

  2021cites this paper
• Experimental and clinical evidence of endothelial dysfunction in inflammatory bowel disease.

  2020cites this paper
• Shedding Light on Hemostasis in Patients With Inflammatory Bowel Diseases.

  2020cites this paper
• Fermentative Foods: Microbiology, Biochemistry, Potential Human Health Benefits and Public Health Issues

  2020cites this paper
• Tuning the Thromboinflammatory Response to Venous Flow Interruption by the Ectonucleotidase CD39

  2019cites this paper
• MMPs, ADAMs and Their Natural Inhibitors in Inflammatory Bowel Disease: Involvement of Oxidative Stress

  2017cites this paper
• Platelets in Inflammatory Bowel Disease

  2017cites this paper
• Platelets Toll‐like receptor‐4 in Crohns disease

  2017cites this paper
• The Role of the Mesentery in Crohn's Disease: The Contributions of Nerves, Vessels, Lymphatics, and Fat to the Pathogenesis and Disease Course

  2016cites this paper
• Platelet activity in the pathophysiology of inflammatory bowel diseases.

  2015cites this paper
• The relationship between coagulation state and inflammatory bowel disease: current understanding and clinical implications

  2015cites this paper
• Hypercoagulability and Platelet Abnormalities in Inflammatory Bowel Disease

  2015cites this paper
• Enhancing haematopoeitic stem cell recruitment to injured murine colon

  2014influential citation
• Increased responsiveness to thrombin through protease-activated receptors (PAR)-1 and -4 in active Crohn's disease.

  2014cites this paper
• Platelet Activation and Platelet-leukocyte Aggregation Elicited in Experimental Colitis Are Mediated by Interleukin-6

  2014cites this paper
• Platelet Abnormalities during Colonic Inflammation

  2013cites this paper
• Interleukin-6 mediates the platelet abnormalities and thrombogenesis associated with experimental colitis.

  2013cites this paper
• An Unusual Case of Acute Abdominal Pain

  2013cites this paper
• Elevated platelet expression of CD36 may contribute to increased risk of thrombo-embolism in active inflammatory bowel disease

  2013cites this paper
• Factor V Leiden and Inflammation

  2012cites this paper
• Platelets: a critical link between inflammation and microvascular dysfunction

  2012cites this paper
• Platelets orchestrate remote tissue damage after mesenteric ischemia-reperfusion.

  2012cites this paper
• Physiological and pathological role of local and immigrating colonic stem cells.

  2012cites this paper
• Current viewpoints on platelet contribution to inflammation

  2012cites this paper
• Platelets Orchestrate Remote Tissue Damage after Mesenteric Ischemia/Reperfusion Running Platelets and Complement in Reperfusion Injury

  2012cites this paper
• Platelet-Associated CD40/CD154 Mediates Remote Tissue Damage after Mesenteric Ischemia/Reperfusion Injury

  2012cites this paper
• Thrombosis 7 Plts : Platelets MPs : Microparticles MVs : Microvesicles

  2012cites this paper
• Update on current applications of proteomic in the study of inflammatory bowel disease

  2012cites this paper
• Enhanced platelet adhesion induces angiogenesis in intestinal inflammation and inflammatory bowel disease microvasculature

  2010cites this paper
• Evaluation of Erythrocytes, Platelets, and Serum Iron Profile in Dogs with Chronic Enteropathy

  2010cites this paper
• Interleukin-1beta mediates the extra-intestinal thrombosis associated with experimental colitis.

  2010cites this paper
• On the dynamics of nitrite, nitrate and other biomarkers of nitric oxide production in inflammatory bowel disease.

  2010cites this paper
• New proteomic approaches for biomarker discovery in inflammatory bowel disease

  2010cites this paper
• Human neutrophil peptides 1–3 are useful biomarkers in patients with active ulcerative colitis

  2009cites this paper
• Lactobacillus reuteri prevents colitis by reducing P-selectin-associated leukocyte- and platelet-endothelial cell interactions.

  2009cites this paper
• New biomarkers of Crohn’s disease: serum biomarkers and development of diagnostic tools

  2008cites this paper
• Imbalance of tissue inhibitors of metalloproteinases (TIMP) – 1 and – 4 serum levels, in patients with inflammatory bowel disease

  2008cites this paper
• Multiple pathogenic roles of microvasculature in inflammatory bowel disease: a Jack of all trades.

  2008cites this paper
• Microarray Analysis of Leukocytapheresis‐induced Changes in Gene Expression Patterns of Peripheral Blood Mononuclear Cells in Patients With Ulcerative Colitis

  2007cites this paper
• Circulating microparticles as therapeutic targets in cardiovascular diseases.

  2007cites this paper
• Modulation of platelet aggregation responses by leukocytapheresis therapy in patients with active ulcerative colitis

  2006cites this paper
• Platelets in inflammatory bowel disease

  2006cites this paper